ClinicalTrials.gg
RecruitingNCT07948304MODS-TASUpdated Nov 19, 2026

Multiple Organ Dysfunction After Thoracic Aortic Surgery With Cardiopulmonary Bypass

An observational study in Multiple Organ Dysfunction Syndrome and Thoracic Aortic Surgery, sponsored by Hanoi Medical University. Recruiting at 1 site in Vietnam. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Hanoi Medical University · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
91
Ages
18 Years and older
Sex
All
01

Study summary

Thoracic aortic surgery with cardiopulmonary bypass (CPB) is one of the most invasive procedures in cardiac surgery. It often requires prolonged CPB and aortic cross-clamp times, and sometimes hypothermic circulatory arrest with selective cerebral perfusion. Multiple organ dysfunction syndrome (MODS) is a leading cause of death and prolonged intensive care unit (ICU) stay after these operations. However, most studies have examined single organ complications, such as acute kidney injury or respiratory failure, and data on MODS as a whole remain limited, particularly in Vietnam. This retrospective cohort study will review the medical records of adult patients who underwent thoracic aortic surgery with CPB at Hanoi Medical University Hospital from September 2019 to September 2026. Organ function will be assessed daily with the Sequential Organ Failure Assessment (SOFA) score from ICU admission until ICU discharge. The study aims to describe the clinical and paraclinical characteristics of these patients, to determine the incidence of postoperative MODS, and to identify preoperative and intraoperative factors associated with MODS.

Read the detailed description

Background. Exposure of blood to the artificial surfaces of the CPB circuit triggers a systemic inflammatory response, with complement and neutrophil activation and release of pro-inflammatory cytokines such as IL-6 and TNF-α. Together with ischemia-reperfusion injury during aortic cross-clamping and circulatory arrest, this leads to endothelial dysfunction, capillary leak and impaired microcirculation. Older age, reduced left ventricular ejection fraction, preoperative renal dysfunction, a high EuroSCORE II, emergency surgery for aortic dissection, and long CPB and cross-clamp times have been associated with postoperative organ dysfunction. Vietnamese series of type A aortic dissection report MODS in about 18.6% of patients and MODS as the cause of 30-60% of early postoperative deaths.

Objectives. (1) To describe the clinical and paraclinical characteristics of patients undergoing thoracic aortic surgery with CPB. (2) To determine the incidence of postoperative MODS and the factors associated with it.

Design and setting. Single-center retrospective cohort study at the Center for Anesthesia, Critical Care and Pain Management, Hanoi Medical University Hospital, Hanoi, Vietnam. All consecutive eligible records from September 1, 2019 to September 30, 2026 will be reviewed; the minimum sample size is 91 patients (single-proportion formula, p = 0.186, d = 0.08, α = 0.05).

Data collection. Data will be abstracted from paper and electronic medical records into a standardized case report form at three phases: (a) preoperative - age, sex, body mass index, comorbidities (hypertension, diabetes, chronic lung disease, stroke, coronary artery disease, heart failure, atrial fibrillation, prior cardiac surgery), NYHA class, ASA class, EuroSCORE II, echocardiography, and baseline renal, hepatic, hematologic and coagulation tests; (b) intraoperative - urgency (emergency vs elective), type of aortic procedure, operative time, CPB time, aortic cross-clamp time, circulatory arrest time, lowest temperature, blood loss, urine output and transfusion of red cells, plasma and platelets; (c) postoperative ICU - heart rate and rhythm, blood pressure, vasoactive and inotropic doses, Glasgow Coma Scale, urine output, arterial blood gases with FiO2, lactate, creatinine, bilirubin and platelet count recorded daily, plus renal replacement therapy, ECMO, duration of mechanical ventilation, ICU and hospital length of stay, and 30-day mortality.

Definitions. Organ dysfunction is scored for six systems (respiratory, coagulation, hepatic, cardiovascular, central nervous system, renal) using the SOFA score each day from ICU admission to ICU discharge; laboratory values within 24 hours of each assessment are used. An organ is considered failing when its SOFA component score is ≥ 1 and persists for ≥ 24 hours. MODS is defined as failure of ≥ 2 organ systems (consistent with an increase in total SOFA score of ≥ 2 points, Sepsis-3). Acute kidney injury is defined and staged by KDIGO 2012 criteria within 7 days after surgery.

Statistical analysis. Categorical variables will be reported as counts and percentages and compared with the chi-square test; continuous variables as mean ± SD or median (range) and compared with the t-test or Mann-Whitney U test. Variables with p \< 0.1 in univariable comparison between patients with and without MODS will enter a multivariable logistic regression model; results will be reported as odds ratios with 95% confidence intervals. Analyses will use SPSS 20.0.

Ethics. The study uses existing medical records only and does not change patient care. Patient identities will be coded and kept confidential, and data will be used only for this research.

02

Conditions studied

  • Multiple Organ Dysfunction Syndrome
  • Thoracic Aortic Surgery

Keywords

  • Multiple organ dysfunction syndrome
  • Thoracic aortic surgery
  • Cardiopulmonary bypass
03

In context

Multiple Organ Failure

195 studies on the registry are indexed under Multiple Organ Failure; 49 are open to participants now.

This study's planned enrollment of 91 is below the median of 200 across 96 observational studies indexed under Multiple Organ Failure.

Browse Multiple Organ Failure studies →

Lead sponsor

Hanoi Medical University is the lead sponsor of 57 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients who underwent elective or emergency thoracic aortic surgery with cardiopulmonary bypass at Hanoi Medical University Hospital between September 1, 2019 and September 30, 2026 and were admitted postoperatively to the Cardiac Surgical Intensive Care Unit

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 years or older
  2. Underwent thoracic aortic surgery (ascending aorta, aortic root including Bentall procedure, aortic arch and/or descending thoracic aorta) with cardiopulmonary bypass at Hanoi Medical University Hospital between September 1, 2019 and September 30, 2026
  3. Medical record available for review

Exclusion criteria

Exclusion Criteria:

  1. Missing data required to calculate the SOFA score: blood pressure and vasoactive drug doses (cardiovascular), urine output (renal), level of consciousness (central nervous system), or arterial blood gas with FiO2 (respiratory)
  2. Multiple organ dysfunction present before surgery
  3. Intraoperative death, or death within the first 24 hours after surgery from causes other than multiple organ dysfunction
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
91 participants (estimated)
Patient registry
No

Groups and cohorts

  • Thoracic aortic surgery with cardiopulmonary bypass

    Adult patients (aged 18 years or older) who underwent elective or emergency thoracic aortic surgery with cardiopulmonary bypass at Hanoi Medical University Hospital between September 1, 2019 and September 30, 2026 and were admitted postoperatively to the Cardiac Surgical Intensive Care Unit. Organ function is assessed daily with the SOFA score from ICU admission to ICU discharge; patients are classified as with or without postoperative multiple organ dysfunction syndrome (failure of 2 or more organ systems) for the risk-factor analysis.

    Procedure: Thoracic aortic surgery with cardiopulmonary bypass

Interventions

  • ProcedureThoracic aortic surgery with cardiopulmonary bypass

    Elective or emergency open surgery on the thoracic aorta (ascending aorta, aortic root including the Bentall procedure, aortic arch and/or descending thoracic aorta) performed with cardiopulmonary bypass, with or without hypothermic circulatory arrest and selective cerebral perfusion, as part of routine clinical care. No intervention is assigned by the study; data are collected retrospectively from medical records.

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative multiple organ dysfunction syndrome (MODS)

    Proportion of patients with failure of ≥ 2 organ systems after surgery. Each of six systems (respiratory, coagulation, hepatic, cardiovascular, central nervous system, renal) is scored daily with the Sequential Organ Failure Assessment (SOFA) score; an organ is considered failing when its component score is ≥ 1 for ≥ 24 hours

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

Secondary outcomes

  1. Association between cardiopulmonary bypass time and postoperative MODS

    Adjusted odds ratio (95% CI) for postoperative MODS per 30-minute increase in cardiopulmonary bypass time, estimated by multivariable logistic regression. MODS is defined as failure of 2 or more organ systems (SOFA component score of 1 or more lasting 24 hours or more).

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

  2. Incidence of individual organ dysfunction

    Proportion of patients with a SOFA component score ≥ 1 lasting ≥ 24 hours for each of the six organ systems

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

  3. Maximum total SOFA score

    Highest daily total SOFA score (0-24 points) during the postoperative ICU stay

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

  4. Incidence and stage of acute kidney injury (KDIGO)

    Acute kidney injury defined and staged (stage 1-3) by KDIGO 2012 criteria using serum creatinine and urine output

    Time frame: Within the first 7 postoperative days

  5. Duration of mechanical ventilation

    Time from postoperative ICU admission to successful extubation, in hours

    Time frame: From ICU admission after surgery until successful extubation, assessed up to 30 days after surgery

  6. ICU length of stay

    Number of days from postoperative ICU admission to ICU discharge

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

  7. Postoperative hospital length of stay

    Number of days from surgery to hospital discharge

    Time frame: From the day of surgery until hospital discharge, assessed up to 30 days after surgery

  8. 30-day mortality

    All-cause death within 30 days after surgery

    Time frame: 30 days after surgery

  9. Association between aortic cross-clamp time and postoperative MODS

    Adjusted odds ratio (95% CI) for postoperative MODS per 30-minute increase in aortic cross-clamp time, estimated by multivariable logistic regression. MODS is defined as failure of 2 or more organ systems (SOFA component score of 1 or more lasting 24 hours or more).

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

  10. Association between preoperative EuroSCORE II and postoperative MODS

    Adjusted odds ratio (95% CI) for postoperative MODS per 1-percentage-point increase in preoperative European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) predicted mortality, estimated by multivariable logistic regression. MODS is defined as failure of 2 or more organ systems (SOFA component score of 1 or more lasting 24 hours or more).

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

  11. Association between emergency surgery for acute aortic dissection and postoperative MODS

    Adjusted odds ratio (95% CI) for postoperative MODS in patients undergoing emergency surgery for acute aortic dissection compared with elective surgery, estimated by multivariable logistic regression. MODS is defined as failure of 2 or more organ systems (SOFA component score of 1 or more lasting 24 hours or more).

    Time frame: From ICU admission after surgery until ICU discharge, assessed up to 30 days after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10. doi: 10.1007/BF01709751. No abstract available. PubMed 8844239 ↗
  • Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287. PubMed 26903338 ↗
  • Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179-84. doi: 10.1159/000339789. Epub 2012 Aug 7. No abstract available. PubMed 22890468 ↗
  • Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5. doi: 10.1093/ejcts/ezs043. Epub 2012 Feb 29. PubMed 22378855 ↗
  • Writing Committee Members; Isselbacher EM, Preventza O, Hamilton Black Iii J, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Woo YJ. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 Dec 13;80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004. Epub 2022 Nov 2. PubMed 36334952 ↗
  • Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 2003 Feb;75(2):S715-20. doi: 10.1016/s0003-4975(02)04701-x. PubMed 12607717 ↗
  • Olsson C, Franco-Cereceda A. Impact of organ failure and major complications on outcome in acute Type A aortic dissection. Scand Cardiovasc J. 2013 Dec;47(6):352-8. doi: 10.3109/14017431.2013.845307. Epub 2013 Oct 16. PubMed 24131200 ↗
  • Gurcu ME, Kulahcioglu S, Karaca Baysal P, Altas O, Celik S, Arslan O, Erkilinc A, Tokgoz HC, Karagoz A, Kirali K. Comparison of sequential organ failure assessment score and cardiac surgery score systems for mortality prediction after emergency acute aortic dissection surgery. Ulus Travma Acil Cerrahi Derg. 2022 Sep;28(9):1298-1304. doi: 10.14744/tjtes.2021.27845. PubMed 36043914 ↗
  • Wang L, Zhong G, Lv X, Dong Y, Hou Y, Dai X, Chen L. Risk factors for acute kidney injury after Stanford type A aortic dissection repair surgery: a systematic review and meta-analysis. Ren Fail. 2022 Dec;44(1):1462-1476. doi: 10.1080/0886022X.2022.2113795. PubMed 36036431 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared due to institutional data protection regulations.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Jan 2027, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 19, 2026
StartActual
Jun 16, 2026
Primary completionEst.
Jan 31, 2027
CompletionEst.
Jul 30, 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948304
Lead sponsor
Hanoi Medical University
Responsible party
Luu Xuan Vo (Principal Investigator, Hanoi Medical University) — Principal investigator
First posted
Nov 19, 2026
Start date
Jun 16, 2026
Primary completion
Jan 31, 2027 (estimated)
Completion
Jul 30, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Tu Nguyen Huu, Prof
Contact
nguyenhuutu@hmu.edu.vn
+84904176397
Minh Quang Pham, PhD
Contact
phamquangminh@hmu.edu.vn
+84912424932
Tu Huu Nguyen, Prof
study chair · Hanoi Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion